Spots Global Cancer Trial Database for Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX
Official Title: An Open Randomised Trial to Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX Monotherapy Induced Gynaecomastia and/or Breast Pain in Prostate Cancer Patients
Study ID: NCT00590213
Conditions
Study Description
Brief Summary: The primary objective of this trial is to examine the value of prophylactic versus therapeutic breast radiotherapy in Casodex monotherapy induced gynaecomastia and/or breast pain. Patients will receive either prophylactic radiotherapy to the breast at a dose of 12Gy (as two fractions of 6 Gy in consecutives days), or will not receive any radiotherapy prior to commencing CASODEX 150mg monotherapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Research Site, Adana, , Turkey
Research Site, Ankara, , Turkey
Research Site, Diyarbak?r, , Turkey
Research Site, Edirne, , Turkey
Research Site, Eskisehir, , Turkey
Research Site, Istanbul, , Turkey
Research Site, Izmir, , Turkey
Research Site, Manisa, , Turkey
Research Site, Samsun, , Turkey
Contact Details
Name: Haluk Ozen, Prof
Affiliation: Hacettepe Univ. Med. Fac
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
